The use ofin vitrotechnologies coupled with high resolution accurate mass LC‐MS for studying drug metabolism in equine drug surveillance
Authors:
- 1 January 2010
- journal article
- research article
- Published by Wiley in Drug Testing and Analysis
- Vol. 2 (1) , 1-10
Abstract
The detection of drug abuse in horseracing often requires knowledge of drug metabolism, especially if urine is the matrix of choice. In this study, equine liver/lung microsomes/S9 tissue fractions were used to study the phase I metabolism of eight drugs of relevance to equine drug surveillance (acepromazine, azaperone, celecoxib, fentanyl, fluphenazine, mepivacaine, methylphenidate and tripelennamine).In vitrosamples were analyzed qualitatively alongside samples originating fromin vivoadministrations using LC‐MS on a high resolution accurate mass Thermo Orbitrap Discovery instrument and by LC‐MS/MS on an Applied Biosystems Sciex 5500 Q Trap.Using high resolution accurate mass full‐scan analysis on the Orbitrap, thein vitrosystems were found to generate at least the two most abundant phase I metabolites observedin vitrofor all eight drugs studied. In the majority of cases,in vitroexperiments were also able to generate the minorin vivometabolites and sometimes metabolites that were only observedin vitro. More detailed analyses of fentanyl incubates using LC‐MS/MS showed that it was possible to generate good quality spectra from the metabolites generatedin vitro. These data support the suggestion of usingin vitroincubates as metabolite reference material in place ofin vivopost‐administration samples in accordance with new qualitative identification guidelines in the 2009 International Laboratory Accreditation Cooperation‐G7 (ILAC‐G7) document.In summary, thein vitroandin vivophase I metabolism results reported herein compare well and demonstrate the potential ofin vitrostudies to compliment, refine and reduce the existing equinein vivoparadigm. Copyright © 2010 John Wiley & Sons, Ltd.Keywords
This publication has 18 references indexed in Scilit:
- Equine cytochrome P450 2C92: cDNA cloning, expression and initial characterizationArchives of Biochemistry and Biophysics, 2009
- Complementary DNA cloning, functional expression and characterization of a novel cytochrome P450, CYP2D50, from equine liverBiochemical Pharmacology, 2008
- Enzyme-assisted synthesis and structure characterization of glucuronide conjugates of eleven anabolic steroid metabolitesSteroids, 2008
- Metabolic studies of turinabol in horsesAnalytica Chimica Acta, 2007
- Enzyme-assisted synthesis and characterization of glucuronide conjugates of neuroactive steroidsSteroids, 2007
- Metabolic studies of methenolone acetate in horsesAnalytica Chimica Acta, 2005
- Discovery, Biosynthesis, and Structure Elucidation of Metabolites of a Doping Agent and a Direct Analogue, Tetrahydrogestrinone and Gestrinone, Using Human HepatocytesAnalytical Chemistry, 2005
- Preparative synthesis of drug metabolites using human cytochrome P450s 3A4, 2C9 and 1A2 with NADPH-P450 reductase expressed in Escherichia coliJournal of Industrial Microbiology and Biotechnology, 2005
- GLUCURONIDATION OF ANABOLIC ANDROGENIC STEROIDS BY RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASESDrug Metabolism and Disposition, 2003
- Enzyme-Assisted Synthesis and Structure Characterization of Glucuronide Conjugates of Methyltestosterone (17α-methylandrost-4-en-17β-ol-3-one) and Nandrolone (estr-4-en-17β-ol-3-one) MetabolitesBioconjugate Chemistry, 2002